BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2014

Position Statistics

Total Positions 78
New Positions 9
Increased Positions 36
Decreased Positions 25
Positions with Activity 61
Sold Out Positions 8
Total Mkt Value (in $ millions) 1,432

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.62%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 1.32%
Healthcare 87.15%
Services 0%
Technology
Transportation
Utilities

78 Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
NOVADAQ TECHNOLOGIES INC COM 3,693 1,380 59.68 311,403
ADMA BIOLOGICS INC COM 3,503 3,503 New 389,193
ONCOTHYREON INC COM 3,480 870 33.33 2,000,000
MASIMO CORP COM 3,410 3,410 New 97,900
TONIX PHARMACEUTICALS HLDG COR COM NEW 3,271 1,469 81.49 501,639
CAS MED SYS INC COM PAR $0.004 2,494 New 1,918,296
BIODEL INC COM NEW 1,516 New 1,330,034
RXI PHARMACEUTICALS CORP NEW COM NEW 704 New 1,126,482
CELSUS THERAPEUTICS PLC SPONSORED ADR NE 358 New 470,877
RAPTOR PHARMACEUTICAL CORP COM 168 168 New 15,558
BROOKDALE SR LIVING INC COM -11,311 Sold Out 0
CHEMOCENTRYX INC COM -6,096 Sold Out 0
DIGIRAD CORP COM -1,507 Sold Out 0
IMPAX LABORATORIES INC COM -32,650 Sold Out 0
LIBERATOR MEDICAL HLDGS INC COM -3,936 Sold Out 0
NATUS MEDICAL INC DEL COM -19,596 Sold Out 0
RITE AID CORP COM -13,819 Sold Out 0
TETRAPHASE PHARMACEUTICALS INC COM -38,399 Sold Out 0


Create your free portfolio